Enterprise Value
62.88M
Cash
1.192B
Avg Qtr Burn
-139.9M
Short % of Float
0.65%
Insider Ownership
23.41%
Institutional Own.
52.90%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GC007g Details B-cell acute lymphoblastic leukemia | Phase 1/2 Data readout | |
GC012F Details Multiple myeloma | Phase 1/2 Data readout | |
GC012F Details Autoimmune disease, Systemic lupus erythematosus | Phase 1/2 Initiation |